\documentclass[10pt]{article}

\usepackage{fullpage}
\usepackage{setspace}
\usepackage{parskip}
\usepackage{titlesec}
\usepackage[section]{placeins}
\usepackage{xcolor}
\usepackage{breakcites}
\usepackage{lineno}
\usepackage{hyphenat}





\PassOptionsToPackage{hyphens}{url}
\usepackage[colorlinks = true,
            linkcolor = blue,
            urlcolor  = blue,
            citecolor = blue,
            anchorcolor = blue]{hyperref}
\usepackage{etoolbox}
\makeatletter
\patchcmd\@combinedblfloats{\box\@outputbox}{\unvbox\@outputbox}{}{%
  \errmessage{\noexpand\@combinedblfloats could not be patched}%
}%
\makeatother


\usepackage{natbib}




\renewenvironment{abstract}
  {{\bfseries\noindent{\abstractname}\par\nobreak}\footnotesize}
  {\bigskip}

\titlespacing{\section}{0pt}{*3}{*1}
\titlespacing{\subsection}{0pt}{*2}{*0.5}
\titlespacing{\subsubsection}{0pt}{*1.5}{0pt}


\usepackage{authblk}


\usepackage{graphicx}
\usepackage[space]{grffile}
\usepackage{latexsym}
\usepackage{textcomp}
\usepackage{longtable}
\usepackage{tabulary}
\usepackage{booktabs,array,multirow}
\usepackage{amsfonts,amsmath,amssymb}
\providecommand\citet{\cite}
\providecommand\citep{\cite}
\providecommand\citealt{\cite}
% You can conditionalize code for latexml or normal latex using this.
\newif\iflatexml\latexmlfalse
\providecommand{\tightlist}{\setlength{\itemsep}{0pt}\setlength{\parskip}{0pt}}%

\AtBeginDocument{\DeclareGraphicsExtensions{.pdf,.PDF,.eps,.EPS,.png,.PNG,.tif,.TIF,.jpg,.JPG,.jpeg,.JPEG}}

\usepackage[utf8]{inputenc}
\usepackage[english]{babel}



\usepackage{float}








\begin{document}

\title{Remdesivir for Covid-19 pneumonia in patients with severe chronic kidney
disease: Case series and review of the literature}



\author[1]{Ahmad Al Bishawi}%
\author[1]{Hamad Abdel Hadi}%
\author[1]{Eman Elmekaty}%
\author[1]{Musaed Al Samawi}%
\author[1]{Arun Nair}%
\author[1]{mohamed aboukamar}%
\author[2]{Muna AlMaslamani}%
\author[3]{Alaaeldin Abdelmajid}%
\affil[1]{Hamad Medical Corporation}%
\affil[2]{Hamad Medical Corp}%
\affil[3]{Hamad General Hospital}%


\vspace{-1em}



  
  \date{May 21, 2024}


\begingroup
\let\center\flushleft
\let\endcenter\endflushleft
\maketitle
\endgroup





\selectlanguage{english}
\begin{abstract}
Remdesivir was the first antiviral agent to receive FDA authorization
for severe COVID-19 management, which restricts its use with severe
renal impairment due to concerns that active metabolites might
accumulate, causing renal toxicities. With limited treatment options,
available evidence on such patient groups is important to assess for
future safety.%
\end{abstract}%



\sloppy


\textbf{Hosted file}

\verb`Remdesivir_-_Final- Submitted.docx`  available at \url{https://authorea.com/users/438539/articles/551402-remdesivir-for-covid-19-pneumonia-in-patients-with-severe-chronic-kidney-disease-case-series-and-review-of-the-literature}

\selectlanguage{english}
\FloatBarrier
\end{document}

